Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Avia Merlender Wagner, Ph.D.
Teva Pharmaceutical Industries Ltd., Israel
Poster(s):
(T1230-10-63) TV-46000, a Novel Long Acting Injectable (LAI) Formulation of Risperidone, Forms a Stable and Robust Subcutaneous Depot, Even under Extreme Conditions: Prediction from Dog and Minipig to Human
Tuesday, October 24, 2023
12:30 PM – 1:30 PM
ET
